1.The efficacy of prevulatory progesterone administration in controlled ovarian hyperstimulation of IVF.
Byung Koo YOON ; Yong Sang SONG ; Seok Hyun KIM ; Jung Gu KIM ; Shin Yong MOON ; Jin Yong LEE ; Yoon Seok CHANG
Korean Journal of Obstetrics and Gynecology 1991;34(11):1561-1567
No abstract available.
Progesterone*
2.Estrogen and progesterone receptors in ovarian tumor with EIA monoclonal assay.
Jae Wook KIM ; Hye Ri SUNG ; Dong Kyu KIM ; Oh Seung YAN ; Chan Ho SONG
Korean Journal of Obstetrics and Gynecology 1993;36(7):2580-2589
No abstract available.
Estrogens*
;
Progesterone*
;
Receptors, Progesterone*
3.The quantitative comparison of specimens by two different centrifu-gation methods in assaying estrogen and progesterone receptors andthe determination of ideal storage time.
Hyeung KIM ; Jin Sook LEE ; Jun Hyeun PARK ; Sook Ja PARK
Korean Journal of Clinical Pathology 1991;11(2):319-332
No abstract available.
Estrogens*
;
Progesterone*
;
Receptors, Progesterone*
4.Estrogen and progesterone receptors in juvenile nasopharyngeal angiofibromas.
Geon CHOI ; Seon Tae KIM ; Sung Won CHAE ; Heung Man LEE ; Soon Jae HWANG
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(6):1219-1224
No abstract available.
Angiofibroma*
;
Estrogens*
;
Progesterone*
;
Receptors, Progesterone*
5.Meningioma with Multiple Recurrences and Malignant Transformation Differences in expression of MIB1, p53 and progesterone receptor.
Korean Journal of Pathology 1997;31(12):1314-1316
We describe herein a case of meningioma showing three recurrences and in the end malignant transformation. To compare the differences of MIB1, p53 and progesterone receptor expressions in benign, recurrent and malignant meningiomas of the same patient, we performed immunohistochemical stainings for those markers. MIB1 and p53 reactivities were increased in proportion to histologic aggressiveness. By contrast, the progesterone receptor expression was noted in benign meningioma but not in malignant meningioma.
Humans
;
Meningioma*
;
Progesterone*
;
Receptors, Progesterone*
;
Recurrence*
6.Estrogen and progesterone receptors in normal and abnormal female reproductive tissues with EIA monoclonal assay.
He Ri SUNG ; Jae Wook KIM ; Dong Kyu KIM ; Chan Ho SONG
Korean Journal of Obstetrics and Gynecology 1991;34(7):948-960
No abstract available.
Estrogens*
;
Female*
;
Humans
;
Progesterone*
;
Receptors, Progesterone*
7.If Progesterone Is Blamed for Breast Cancer Development, Why Are We Still Using Tamoxifen?.
Enis OZKAYA ; Vakkas KORKMAZ ; Tuncay KUCUKOZKAN ; Fadil KARA
Journal of Breast Cancer 2013;16(1):131-131
No abstract available.
Breast
;
Breast Neoplasms
;
Progesterone
8.Comparison of estrogen receptor-alpha, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.
Eun Hee KIM ; Joo Young KIM ; Yoon Hee LEE ; Gun Oh CHONG ; Ji Young PARK ; Dae Gy HONG
Obstetrics & Gynecology Science 2014;57(2):144-150
OBJECTIVE: This study was aimed to compare immunohistochemical expression of estrogen receptor (ER)-alpha, progesterone receptor (PR), and calponin in gonadotrophin-releasing hormone agonist (GnRH-a)-sensitive and -resistant uterine fibroids. METHODS: We collected data retrospectively. The sensitive group consisted of women who had reduction in uterine volume greater than 40% following GnRH-a treatment. Uterine volume was either reduced by less than 10%, or was increased in the resistant group. A tissue microarray was constructed using formalin-fixed, paraffin-embedded tissues, 31 and 26 patients for the sensitive and resistant groups, respectively. Tissue sections were immunostained with antibodies against ER-alpha, PR, and calponin. The intensity and area of the immunohistochemical reactions were evaluated using a semi-quantitative scoring system. The Mann-Whitney U-test, Fisher's exact test, and Spearman's rank correlation test were used for analysis of data. RESULTS: PR (P = 0.04) and calponin (P = 0.03) showed a significantly higher staining intensity in the resistant group than in the sensitive group. Both groups showed comparable expression of ER-alpha (P = 0.23). In correlation analysis between changes in uterine volume after GnRH-a therapy and clinicopathological factors, the immunohistochemical intensity of PR (P = 0.04) and calponin (P = 0.03) was significantly correlated with changes in uterine volume. CONCLUSION: This study shows that GnRH-a resistance of uterine fibroids is not related to ER-alpha content, but the expression of PR and calponin is related with GnRH-a resistance.
Antibodies
;
Estrogens*
;
Female
;
Humans
;
Leiomyoma*
;
Progesterone*
;
Receptors, Progesterone*
;
Retrospective Studies
9.Estrogen and progesterone receptors in the human fallopian tubes.
Young Ja PARK ; Chan Ho SONG ; In Sook SOHN ; Dong Jae CHO
Korean Journal of Obstetrics and Gynecology 1992;35(8):1160-1169
No abstract available.
Estrogens*
;
Fallopian Tubes*
;
Female
;
Humans*
;
Progesterone*
;
Receptors, Progesterone*
10.The change of estrogen and progesterone receptors in uterine myoma after treatment with GnRH analogue.
Ki Hyun PARK ; Won Il PARK ; Bo Yeon LEE ; Byung Suk LEE ; Dong Jae CHO ; Dong Hoon HWANG ; Chan Ho SONG
Korean Journal of Obstetrics and Gynecology 1993;36(7):1913-1918
No abstract available.
Estrogens*
;
Gonadotropin-Releasing Hormone*
;
Leiomyoma*
;
Progesterone*
;
Receptors, Progesterone*
Result Analysis
Print
Save
E-mail